09:47 AM EDT, 08/29/2024 (MT Newswires) -- Scilex Holding ( SCLX ) said Thursday that the US Food and Drug Administration has approved the company's supplemental new drug application for precision dosing of the Gloperba label.

Gloperba is an FDA-approved liquid formula of colchicine, an anti-gout medicine, for the prophylaxis of acute gout flares in adults, the company said.

Price: 1.09, Change: -0.02, Percent Change: -1.80